The paid report tracks more than 50 peptide conjugates in clinical trials and 18 proprietary platforms, with most activity in cancer.
Recap by typeshit. Full story at Yahoo Finance.
The Scientist weighs whether GLP-1 drugs could lengthen life and finds the answer still unsettled. Tap through for where the research stands.
The review covers 47 peptides from meat, leather and seafood waste and cites a 12-trial meta-analysis showing a systolic drop of about 5 mmHg, credited to the authors.
Researchers think orexin drugs could expand into ADHD and fatigue the way GLP-1s grew past diabetes. Alkermes reported early ADHD results in 50 adults.
Researchers report in Amino Acids that the peptide blocks HMGA2 at the IL6 promoter in a cell model. The authors note the work is cell culture only, far from any human use.
BusinessWorld Online covers new trial results for Lilly's retatrutide and what the drug could mean for patients going forward.
An explainer on the generic version of the oral Wegovy pill. Few details are available beyond the headline, so tap through for the full piece.
Loading…